Investor Sumitomo Chemical Co., Ltd.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Sumitomo Chemical Co., Ltd. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2024-04-02 13G/A ROIV / Roivant Sciences Ltd. 71,251,083 0
2024-02-01 13G/A ROIV / Roivant Sciences Ltd. 86,367,360 71,251,083
2023-03-10 13D/A MYOV / Myovant Sciences Ltd 50,041,181 45,798,176
2023-03-06 13D/A MYOV / Myovant Sciences Ltd 50,041,181 50,041,181
2023-02-03 13G/A ROIV / Roivant Sciences Ltd. 86,367,360 86,367,360
2022-10-24 13D/A MYOV / Myovant Sciences Ltd 50,041,181 50,041,181
2022-10-03 13D/A MYOV / Myovant Sciences Ltd 50,041,181 50,041,181
2022-02-01 13G ROIV / Roivant Sciences Ltd. 86,367,360
2021-10-27 13D/A MYOV / Myovant Sciences Ltd 49,678,522 50,041,181
2021-09-17 13D/A MYOV / Myovant Sciences Ltd 48,641,181 49,678,522
2021-05-17 13D/A MYOV / Myovant Sciences Ltd 48,468,472 48,641,181
2021-03-30 13D/A UROV / Urovant Sciences Ltd 22,963,263 22,963,479
2020-11-12 13D/A UROV / Urovant Sciences Ltd 22,860,013 22,963,263
2020-05-15 13D/A MYOV / Myovant Sciences Ltd 48,468,472
2020-04-16 13D/A MYOV / Myovant Sciences Ltd 46,508,604 47,488,604
2020-03-26 13D/A MYOV / Myovant Sciences Ltd 45,396,404 46,508,604
2020-03-18 13D/A MYOV / Myovant Sciences Ltd 45,008,604 45,396,404
2020-01-06 13D UROV / Urovant Sciences Ltd 22,860,013
2020-01-06 13D MYOV / Myovant Sciences Ltd 45,008,604
2020-01-03 13D UROV / Urovant Sciences Ltd 22,860,013
2020-01-03 13D MYOV / Myovant Sciences Ltd 45,008,604